Lower-dose radiotherapy effective, safe for HPV+ head and neck cancer after induction chemo

Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papilloma-virus, including those with advanced nodal disease, can receive substantially lower radiotherapy doses safely and effectively if they respond to induction chemotherapy initially.
Medical Xpress